510(k) Report

510(k) · Cleared

Cleared

Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15)

K150064510(k) TraditionalCleared Sep 4, 2015234-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orthogem, Ltd. · MQV Filler, Bone Void, Calcium Compound

Cleared on Sep 4, 2015 as substantially equivalent to K070132 (Orthogem Limited, 2007) and 1 other predicate after a 234-day review. Its family tree reaches back 6 generations to 2002.

Decided
Sep 4, 2015
Review
234 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K013966 (2002). 18 ancestors in all, the oldest K994337 (2000). No later device cites it as a predicate yet.

  1. Root · 6 generations backK013966 Apatight-TCP Bone Graft SubstituteCerabio, LLC · 2002
  2. 5 generations backK022629 WMT-TCP Bone Graft SubstituteWrightmedicaltechnologyinc · 2002
  3. 4 generations backK031817 Cellplex TCP Synthetic Cancellous BoneWrightmedicaltechnologyinc · 2003
  4. 3 generations backK043261 Harvest Graft Delivery SyringeHarvest Technologies, Corp. · 2005 · Recalled
  5. 2 generations backK100754 Graft Delivery System Model SA-6115Micromedics, Inc. · 2010
  6. 1 generation backK110787 Tripore TDD (HA), Tripore TDD (BP90), Tripore TDD (BP15)Orthogem Limited · 2011
  7. This deviceK150064 Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15)Orthogem, Ltd. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K013966Apatight-TCP Bone Graft SubstituteCerabio, LLC2002—
−5K022629WMT-TCP Bone Graft SubstituteWrightmedicaltechnologyinc2002—
−4K031817Cellplex TCP Synthetic Cancellous BoneWrightmedicaltechnologyinc2003—
−3K043261Harvest Graft Delivery SyringeHarvest Technologies, Corp.20052
−2K100754Graft Delivery System Model SA-6115Micromedics, Inc.2010—
−1K110787Tripore TDD (HA), Tripore TDD (BP90), Tripore TDD (BP15)Orthogem Limited2011—
0 (this device)K150064Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15)Orthogem, Ltd.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200140
200230
200310
200410
200720
FIG. 1 — Lineage of K150064, 2002–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070132Tripore, Models HA, BP90, BP15
Summary page 4
…rols per 21 CFR 888.3045. Product code: MQV Predicate Devices TriPore (K070132) TriPore TDD (K110787) Device Description Synthetic bone graft granule…
Orthogem Limited2007—
*K110787Tripore TDD (HA), Tripore TDD (BP90), Tripore TDD (BP15)
Summary page 4
…45. Product code: MQV Predicate Devices TriPore (K070132) TriPore TDD (K110787) Device Description Synthetic bone graft granules of one of the following three materials…
Orthogem Limited2011—

Also cleared against K070132: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 6 companies; a new generation was cleared every 1.7 years on median.
  • 2 of the 18 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K070132.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

TriPore HA, TriPore BP90, TriPore BP15, is a synthetic bone graft intended to be packed into bone defects of the skeletal system (extremities, posterolateral spine, or pelvis) which are not intrinsic to the stability of the bony structure. These defects may be surgically created voids or from traumatic injury to the bone. The device gradually resorbs and is replaced with bone during the healing process. Rigid fixation techniques should be used in conjunction with this device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K150064: Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K150064

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026